China’s Sinopharm, known to have claimed to have developed a COVID-19 vaccine, has invited Pakistan’s National Institute of Health for clinical trials. Via the “HealthBee Projects Private Limited,” the Chinese group will invite Pakistan to participate in the study.
Sinopharma, owned by the State (e.g. People’s Republic of China), reports it is one of the “first” organizations to have led the development of a vaccine for SARS-CoV-2. In a recent report, they touted that 80% of the mandatory immunization needs in the world’s most populous nation are led by this firm now helping to lead the fight against COVID-19.
TrialSite News has reported on the recent approvals by Chinese authorities, two different experimental coronavirus vaccines involving a unit of Sinovac Biotech and the Wuhan Institute of Biological Products. And in March, the regulatory authorities approved a study for an Academy of Military Medical Sciences along with their private sector partner CanSino Bio.
Who is HealthBee Projects?
HealthBee Projects was set up in Pakistan to help assess gaps in medical care with an emphasis on affordable medical services. They collaborate with leading medical companies locally and internationally. They are affiliated with Servaid Pharmacy (Pvt.) Ltd, which has an extensive network of shops and pharmacies with 40 stores operational in Lahore, Daska, Gujranwala, and Sialkot.